Insiders Bio-Rad Laboratories, Inc. Nyse

Equities

BIO.B

US0905721082

Real-time Estimate Cboe BZX Other stock markets 01:21:56 14/05/2024 am IST			5-day change	1st Jan Change
285.3 ^USD	+1.93%		-14.31%	-12.71%

08/05	UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating	MT
08/05	RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group	26/04	CI
Bio-Rad Laboratories COO Andrew Last to Retire in September	11/04	MT
Bio-Rad Laboratories, Inc. Announces Chief Operating Officer Andrew Last to Retire	11/04	CI
Bio-Rad Laboratories Appoints Roop Lakkaraju as CFO	20/03	MT
Bio-Rad Laboratories, Inc. Appoints Roop K. Lakkaraju as New Executive Vice President Effective April 15, 2024	20/03	CI
Bio-rad Laboratories Insider Sold Shares Worth $1,008,000, According to a Recent SEC Filing	29/02	MT
Bio-Rad Laboratories, Inc. Appoints Norman Schwartz as Principal Financial Officer	15/02	CI
Bio-rad Laboratories Insider Sold Shares Worth $358,992, According to a Recent SEC Filing	13/12	MT
Bio-Rad Laboratories, Inc. Announces Resignation of Dara Grantham Wright as Executive Vice-President and President, Effective January 12, 2024	08/12	CI
Bio-rad Laboratories Insider Sold Shares Worth $195,874, According to a Recent SEC Filing	29/11	MT
Viavi Solutions Appoints New CFO	19/23/19	MT
Bio-Rad Laboratories, Inc. Announces Resignation of Ilan Daskal, Executive Vice-President and Principal Financial Officer, Effective November 6, 2023	18/23/18	CI
Bio-Rad Laboratories, Inc. Announces Resignation of Ilan Daskal, Chief Financial Officer, Effective November 6, 2023	18/23/18	CI
Bio-Rad Laboratories EVP Ernst Sells 2,350 Shares for $929,667	31/23/31	MT
Bio-Rad Laboratories, Inc. Announces Executive Changes, Effective September 18, 2023	26/23/26	CI
Insider Sell: Bio-Rad Laboratories	16/23/16	MT
Credit Suisse Initiates Coverage of 20 Companies in Life Science Tools, Services, Diagnostics Sectors; Outperform-Rated Bio-Rad, IQVIA, Bipo-Techne, Natera Named Top Picks	25/22/25	MT
Bio-Rad Laboratories, Inc. Announces Board Changes	29/22/29	CI
Bio-Rad Laboratories, Inc. Announces Executive Changes	16/21/16	CI
Bio-Rad Laboratories, Inc. Announces Executive Changes, Effective January 4, 2022	05/21/05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Bio-Rad Laboratories, Inc. Nyse

Equities

BIO.B

US0905721082

Insiders

Filters